Abstract:Colorectal cancer (CRC) is a very common metastatic tumor with active angiogenesis that requires active angiogenesis. Recently, increased microRNA-181a-5p (miR-181a) expression was found to be significantly associated with liver metastasis and poor outcome in CRC patients. In this study, the role of miR-181a in tumor angiogenesis was further investigated. Capillary tube formation assays were used to demonstrate the ability of miR-181a to promote tumor angiogenesis. Bioinformatics analyses identified SRC kinase signaling inhibitor 1 (SRCIN1) as a potential target of miR-181a. Next, two CRC cell lines (HT29 and SW480) were used to clarify the function of miR-181a through SRCIN1 targeting. In addition, the biological effects of SRCIN1 inhibition by miR-181a were examined in vitro by quantitative RT-PCR, western blotting and enzyme-linked immunosorbent assay and in vivo by Matrigel plug angiogenesis assays and immunohistochemical staining. In clinical samples, Fluorescence in situ hybridization and immunofluorescence were performed to detect the relation between miR-181a and SRCIN1. In addition, SRCIN1 protein and miR-181a expression levels in CRC tissues were also measured by western blot and quantitative real-time polymerase chain reaction. MiR-181a markedly augmented the capability of CRC cells to advance tube formation in endothelial cells in vitro . The Matrigel plug assay showed that miR-181a promoted angiogenesis in vivo . In conclusion, miR-181a inhibited SRCIN1, which caused SRC to transform from an inactive status to an active conformation and to trigger vascular endothelial growth factor secretion, leading to increased angiogenesis. MiR-181a dysregulation contributes to angiogenesis in CRC, and downregulation of miR-181a represents a promising, novel strategy to achieve an efficient antiangiogenic response in anti-CRC therapy.

miR-320 regulates tumor angiogenesis driven by vascular endothelial cells in oral cancer by silencing neuropilin 1

Microrna-320A Inhibits Tumor Invasion by Targeting Neuropilin 1 and is Associated with Liver Metastasis in Colorectal Cancer.

Microrna-320A Inhibits Tumor Invasion by Targeting Neuropilinï¿½1 and is Associated with Liver Metastasis in Colorectal Cancer

MicroRNA 320, an Anti-Oncogene Target miRNA for Cancer Therapy

A MicroRNA302-367-Erk1/2-Klf2-S1pr1 Pathway Prevents Tumor Growth via Restricting Angiogenesis and Improving Vascular Stability.

MicroRNA-320a inhibits proliferation and invasion of breast cancer cells by targeting RAB11A.

Abstract 23: Microrna302-367 Sphingosine 1 Phosphate Receptor 1 Pathway Prevents Tumor Growth Via Restricting Angiogenesis and Enhancing Vascular Stability

Downregulation of Microrna 99a in Oral Squamous Cell Carcinomas Contributes to the Growth and Survival of Oral Cancer Cells.

Mir‑140‑5p Regulates Cell Migration and Invasion of Non‑small Cell Lung Cancer Cells Through Targeting VEGFA.

MiR-181b suppresses angiogenesis by directly targeting cellular communication network factor 1

MicroRNA-181a promotes angiogenesis in colorectal cancer by targeting SRCIN1 to promote the SRC/VEGF signaling pathway

miR-320a suppresses colorectal cancer progression by targeting Rac1.

Tumor-Derived Microrna-494 Promotes Angiogenesis in Non-Small Cell Lung Cancer

MicroRNA-320a Inhibits Breast Cancer Metastasis by Targeting Metadherin

miR-3200 accelerates the growth of liver cancer cells by enhancing Rab7A

Mir-409-3p Inhibits HT1080 Cell Proliferation, Vascularization and Metastasis by Targeting Angiogenin.

Extracellular vesicle-derived miR-320a targets ZC3H12B to inhibit tumorigenesis, invasion, and angiogenesis in ovarian cancer

Tumor Cell-Secreted Angiogenin Induces Angiogenic Activity of Endothelial Cells by Suppressing Mir-542-3p

MEG3-Mediated Oral Squamous-Cell-Carcinoma-Derived Exosomal miR-421 Activates Angiogenesis by Targeting HS2ST1 in Vascular Endothelial Cells

miR-320a regulates high mobility group box 1 expression and inhibits invasion and metastasis in hepatocellular carcinoma.

Global Microrna Depletion Suppresses Tumor Angiogenesis.